SGLT-2is improve several parameters including weight and BMI, but may also reduce muscle mass.

Takeaway

• Sodium-glucose cotransporter 2 inhibitors (SGLT-2is) improve body composition in type 2 diabetes (T2D), including body weight, BMI, waist circumference (WC), visceral fat area, subcutaneous fat area, percentage body fat, and fat mass reduction.
• However, adversely,...